Quercetin in lyotropic liquid crystalline formulations: Physical, chemical and functional stability


Autoria(s): VICENTINI, Fabiana T. M. C.; CASAGRANDE, Rubia; VERRI JR., Waldiceu A.; GEORGETTI, Sandra R.; BENTLEY, M. Vitoria L. B.; FONSECA, Maria J. V.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2008

Resumo

The purpose of this study was to develop a lyotropic liquid crystalline formulation using the emulsifier vitamin E TPGS and evaluate its behavior after incorporation of a flavonoid, quercetin. The physical (macro and microscopic), chemical (determination of quercetin content by the HPLC method) and functional (determination of quercetin antioxidant activity by DPPH center dot assay) stability of the lamellar liquid crystalline formulation containing flavonoid was evaluated when stored at 4+/-2 degrees C; 30+/-2 degrees C/70+/-5% RH (relative humidity) and 40+/-2 degrees C/70+/-5% RH during 12 months. The lamellar liquid crystalline structure of the formulation was maintained during the experiment, however chemical and functional stability results showed a great influence of the storage period in all conditions tested. A significant decrease in quercetin content (approximately 40%) was detected during the first month of storage and a similar significant loss in antioxidant activity was detected after 6 months. The remaining flavonoid content was unchanged during the final 6 months of the experimental period. The results suggest possible interactions between quercetin and the liquid crystalline formulation, which could inhibit or reduce the quercetin activity incorporated in the system. In conclusion, the present study demonstrated that incorporation of quercetin (1%) did not affect the liquid crystalline structure composed of vitamin E TPGS/IPM/PG-H2O (1:1) at 63.75/21.25/15 (w/w/w). Nevertheless, of the total quercetin incorporated in the system only 60% was free to act as an antioxidant.

Identificador

AAPS PHARMSCITECH, v.9, n.2, p.591-596, 2008

1530-9932

http://producao.usp.br/handle/BDPI/20090

10.1208/s12249-008-9091-3

http://dx.doi.org/10.1208/s12249-008-9091-3

Idioma(s)

eng

Publicador

SPRINGER

Relação

Aaps Pharmscitech

Direitos

closedAccess

Copyright SPRINGER

Palavras-Chave #antioxidant #DPPH center dot #HPLC #liquid crystals #quercetin #stability #DRUG-DELIVERY SYSTEMS #VITAMIN-E TPGS #IN-VITRO #TOPICAL DELIVERY #OXIDATIVE STRESS #NANOPARTICLES #RELEASE #PENETRATION #FLAVONOIDS #PHASES #Pharmacology & Pharmacy
Tipo

article

original article

publishedVersion